William Szablewski

William Szablewski has over 20 years of experience in finance and capital markets. William is currently the Head of Capital Markets at Viatris.

Previously, they were the Global Finance Director, CNS and Pain Care at Teva Pharmaceuticals from November 2012 to March 2015. In this role, they were responsible for long term strategic/financial planning, M&A, global pipeline, and ex-US regional development.

From April 2015 to September 2020, they were the Assistant Treasurer, Capital Markets at Bristol-Myers Squibb. In this role, they were responsible for capital markets activities for the company, including debt and equity financing, risk management, and investor relations.

Prior to their role at Bristol-Myers Squibb, they were the Associate Director - US Neuroscience Finance at Verizon from January 2008 to November 2012. In this role, they were the finance lead supporting the US Pharmaceutical Neuroscience/Abilify sales and marketing organization.

Before joining Verizon, Szablewski worked at Bristol-Myers Squibb as Sr. Staff Consultant - Financing & Investment from June 1998 to January 2008. In this role, they were responsible for domestic treasury group activities, including long term debt issuance, call analysis and re-opens, interest/Fx/fuel hedging, stock repurchase, credit facility, and short term corporate investing.

William Szablewski received their Bachelors of Science in Finance from Virginia Tech. Afterwards, they attended Drexel University to earn their MBA in Finance & Risk Management. William started their educational career at Holy Ghost Prep, a high school. William is also certified from the CFA Institute as a CFA.

William Szablewski reports to Michael Goettler, CEO. Some of their coworkers include Sanjeev Narula - CFO, Jeffrey Liu - Head of Global Compliance Operations, and Tony Mauro - President, Developed Markets.